Bayer Settles for $133 Million in PCB Cleanup for Two States

• Michigan receives at least $108 million and Rhode Island at least $25 million, with potential additional payments of up to $176 million and $50 million respectively if Bayer wins its indemnification lawsuit against six legacy PCB buyers
• PCBs were widely used in electrical equipment, paper, caulking, and paint until banned by the U.S. government in 1979 due to links to cancer and other health problems
• Bayer acquired Monsanto for $63 billion in 2018 and has since faced extensive litigation over both PCBs and Roundup weedkiller claims across municipalities, states, schools, and individuals

Summary

Key Development: Bayer's Monsanto unit has agreed to pay at least $133 million to settle polychlorinated biphenyl (PCB) contamination claims from Michigan and Rhode Island. Michigan will receive a minimum of $108 million, while Rhode Island gets at least $25 million to fund cleanup efforts of contaminated water, soil, and wildlife.

Settlement Details: This marks Bayer's 12th state-level PCB settlement, following recent agreements with Illinois and West Virginia in December. The settlement includes no admission of wrongdoing, though total payments could increase significantly—Michigan could receive up to $284 million ($108M + $176M contingency) and Rhode Island up to $75 million ($25M + $50M contingency)—depending on the outcome of Bayer's 2023 lawsuit against six PCB buyers in Missouri federal court seeking indemnification.

Background: Monsanto produced PCBs from 1935 to 1977 for use in electrical equipment insulation, carbonless copy paper, caulking, and paint. The U.S. government banned PCBs in 1979 after linking them to cancer and serious health problems. Bayer acquired Monsanto for $63 billion in 2018 and has since faced extensive litigation over both PCB contamination and Roundup weedkiller cancer claims.

Market Implications: The ongoing settlements represent a significant legacy liability for Bayer, adding to the company's already substantial legal burden from the Monsanto acquisition. With lawsuits coming from municipalities, states, schools, property owners, and individuals claiming PCB-related illnesses, the full financial impact remains uncertain. The company maintains it provided appropriate safety warnings based on scientific knowledge available at the time of production.